MedTrace Logo

Untersuchung Zur Erfassung Und Kontrolle Der Lebensqualität Unter Einer Therapie Mit Pollinex Quattro Bei Heuschnupfen

NCT03014661 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 58

Last updated 2017-01-09

No results posted yet for this study

Summary

Questionnaire to measure and control the quality of life of patients with hay fever who are treated or were treated with Pollinex quattro

Conditions

  • Rhinitis, Allergic, Seasonal

Interventions

OTHER

Quality of life under or after therapy with Pollinex quattro

To measure Quality of life using the DLQI-index in year one, year two, year three or six month after therapy with Pollinex quattro plus.

Sponsors & Collaborators

  • Universität des Saarlandes

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03014661 on ClinicalTrials.gov